USPTO serial 85235852
RX SUZUKA
Reviewed by CopyMark Law Group
Reg. 4274054Status 710
- Filing date
- Status date
- Registration date
- Jan 15, 2013
- Examiner
- TOOLEY, DAVID E
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with RX SUZUKA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Richard J. Groos
Richard J. Groos Fulbright & Jaworski L.L.P.98 San Jacinto Blvd., Suite 1100Austin, TX 78701UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals in the field of biomarker diagnostics used in industry, science, photography, agriculture, horticulture and forestry except fungicides, herbicides, insecticides and parasiticides; chemical reagents for non-medical purposes, namely, biomarkers; enzymes and raw proteins for scientific and research purposes, namely, biomarkers; diagnostic preparations for scientific purposes; diagnostic preparations, namely, biomarkers for analysis of food products and water and all the aforesaid for sale in kit form; clinical diagnostics preparations for clinical or medical laboratory use in the field of biomarker diagnostics; diagnostic scanning agents for scientific and research use, namely, biomarkers; diagnostic testing material, namely, testing of biochemical markers for scientific and research use, all of the foregoing not having to do with the design or development of drugs | SECTION 8 - CANCELLED | — |
| 005 | Antitoxic sera and antisera for diagnostic purposes; diagnostic preparations for medical and veterinary use, namely, biomarkers; diagnostic preparations for sale in kit form for medical and veterinary use related to biomarkers; diagnostic scanning agents, namely, biomarkers for medical and veterinary use; clinical diagnostic preparations for medical and veterinary use in the field of biomarkers; diagnostic testing preparations for medical and veterinary use in the field of biomarkers; reagents for use in diagnostic tests for medical and veterinary purposes in the field of biomarkers; diagnostic reagents for use with analyzers for medical and veterinary purposes in the field of biomarkers, all of the foregoing not having to do with the design or development of drugs | SECTION 8 - CANCELLED | — |
| 009 | Computer software for scheduling, programming, analysing and reporting on diagnostic tests in the field of biomarkers; computer software for automatic calibration, barcode scanning, reagent information management, reaction process monitoring and cross-contamination prevention in the field of biomarkers; computer software for patient information memory and association input, report auditing, printing and publishing diagnostic test results and statistics in the field of biomarkers; detectors for chemical compounds and reagents in the field of biomarkers; diagnostic apparatus and instruments for the testing of clinical chemistry, toxicology, food and wine, not for medical purposes; diagnostic testing apparatus and instruments for use in immunoassay procedures, not for medical purposes; diagnostic imaging apparatus for the study of chemical compounds and structures other than for medical use; clinical laboratory analytical instruments, namely, clinical chemistry or immunoassay analysers, other than for medical use, all of the foregoing not having to do with the design or development of drugs | SECTION 8 - CANCELLED | — |
| 010 | Medical apparatus and instruments for use in biomarker diagnostics; diagnostic apparatus and instruments for medical use, namely, biomarkers for detecting and analysing infectious and non-infectious diseases, organ function in humans and animals, therapeutic drugs and drugs of abuse, proteins, acids and antioxidants; clinical chemistry analyzers for disease, toxicology and bodily function analysis for medical and veterinary use in the field of biomarker diagnostics; diagnostic testing apparatus and instruments for use in immunoassay procedures; clinical laboratory analytical instruments for medical and veterinary use, namely, apparatus for clinical diagnosis in the field of biomarkers, all of the foregoing not having to do with the design or development of drugs | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Randox Laboratories Ltd
- Other trademarks owned by Randox Laboratories Ltd
- Other trademarks owned by Randox Laboratories Ltd
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named RX SUZUKA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 16, 2019 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jan 15, 2018 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jan 15, 2013 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 30, 2012 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 30, 2012 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 10, 2012 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 2, 2012 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Aug 21, 2012 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 15, 2012 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 15, 2012 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 15, 2012 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 15, 2012 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 15, 2012 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 6, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 6, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 5, 2012 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 5, 2012 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 5, 2012 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 5, 2012 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 1, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 1, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 28, 2011 | ALIE | ASSIGNED TO LIE | — |
| Nov 8, 2011 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 18, 2011 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 9, 2011 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 9, 2011 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 9, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 6, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 10, 2011 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 10, 2011 | NWAP | NEW APPLICATION ENTERED | — |